“The Phase 3 study currently has 169 enrolled pa
Post# of 148174
(Total Views: 621)
Posted On: 08/04/2020 4:54:12 PM
“The Phase 3 study currently has 169 enrolled patients and the Company will conduct a full interim analysis once 195 patients are enrolled, as provided in the trial’s protocol”
Ok so I read the PR again, so we have 26 left to enroll. Let’s just assume we get the other 26 in by August 21st. Few weeks from now.
By September 18th or so we will the 28 day read out from the last enrollment date if we get that many people enrolled by then. Maybe as late as the first week of October.
Didn’t we open a new trial site in Texas ? Maybe enrollment will go a little faster.
Ok so I read the PR again, so we have 26 left to enroll. Let’s just assume we get the other 26 in by August 21st. Few weeks from now.
By September 18th or so we will the 28 day read out from the last enrollment date if we get that many people enrolled by then. Maybe as late as the first week of October.
Didn’t we open a new trial site in Texas ? Maybe enrollment will go a little faster.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼